cilengitide has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Cloughesy, T; Deangelis, LM; Gilbert, MR; Kuhn, J; Lamborn, KR; Lassman, AB; Lieberman, F; Mehta, M; Prados, M; Wen, PY | 1 |
| Akella, NS; Carson, K; Cloud, GA; Colevas, AD; Fisher, JD; Grossman, SA; Hochberg, F; Mikkelsen, T; Nabors, LB; Rosenfeld, SS; Wittemer, SM; Zhang, Y | 1 |
2 trial(s) available for cilengitide and Recrudescence
| Article | Year |
|---|---|
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Female; Glioblastoma; Humans; Immunotherapy; Integrins; Karnofsky Performance Status; Male; Middle Aged; Recurrence; Snake Venoms | 2012 |
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Cohort Studies; Glioma; Humans; Magnetic Resonance Imaging; Maximum Tolerated Dose; Recurrence; Snake Venoms | 2007 |